APPLICATION
ANDA091212
TYPE
ANDA
ORIGINAL APPROVAL
2013-09-16
LATEST ACTION
2015-03-18
ROUTE
ORAL
DOSAGE FORM
CAPSULE, DELAYED REL PELLETS
MARKETING STATUS
Discontinued
Products
LANSOPRAZOLEDiscontinued
LANSOPRAZOLE 15MG · CAPSULE, DELAYED REL PELLETS · ORAL
LANSOPRAZOLEDiscontinued
LANSOPRAZOLE 30MG · CAPSULE, DELAYED REL PELLETS · ORAL
Approval history
2015-03-18Labeling · Supplement 1 · standardAP
2013-09-16OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.